Posted Mar. 19, 2013 at 12:57 p.m.
Arbovax
Raleigh, N.C. — The Raleigh company, a spinout from North Carolina State University, announced it has validated its vaccine technology in animal tests and will now move on to phase I clinical trials of its Dengue vaccine candidate....
Arbovax's Dengue vaccine is now ready for clinical trials
Post a comment
Print this blog postE-mail blog post
Share
Arbovax
Raleigh, N.C. — The Raleigh company, a spinout from North Carolina State University, announced it has validated its vaccine technology in animal tests and will now move on to phase I clinical trials of its Dengue vaccine candidate....
WRAL Tech Wire any time: Twitter, Facebook
Copyright 2013 WRAL Tech Wire. All rights reserved.Please log in or register to view WRALTechWire Insider content
To access this premium content and other benefits, become a WRAL TechWire Insider. Daily, monthly, and annual memberships available.
Please Log In to add a comment.
Best of TechWire Insider
OUR INSIDERS
WRAL TechWire Editor
The Skinny
Duke's Vivek Wadhwa cracks Time 'Most Influential' list- IBM layoff update: North American cuts climb; mum is word down under
- At last! Sprint 4G service formally launches in Triangle
- Big Blue's layoff total climbs in RTP; North America total surges past 2,800
- Big Blue layoff count nears 2,800 in North America alone
- NC's high-tech job picture improves in May, but ...
- IBM layoff count hits nearly 2,300 across 31 work groups
- NC IDEA: Startup deal flow 'better than it has ever been'
- IBM's job cuts are global, nearing 4,000; most are in U.S.
- CEO fears for future of NC Biofuels Center due to budget cuts